Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis

PHASE3CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

August 3, 2018

Primary Completion Date

July 3, 2019

Study Completion Date

September 17, 2019

Conditions

Hyperhidrosis Primary Focal Axilla

Interventions

DRUG

Meditoxin

50U of MEDITOXIN is injected intradermally to each axilla

OTHER

Placebo

normal saline is injected intradermally to each axilla

Trial Locations (1)

Catholic University St. Paul Hospital, Seoul

All Listed Sponsors

lead

Medy-Tox

INDUSTRY

NCT03760198 - Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis | Biotech Hunter | Biotech Hunter